Companhia Brasileira de Distribuicao CBDBY
0.66
0.00
0.00%
as of 24 Dec
- Market cap
- $218.1M
- P/E
- 0.0×
Follow CBDBY
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | — | — | — |
P/S ratio |
0.10 | — | — | — | |
P/FCF ratio |
2.19 | — | — | — | |
P/Operating CF |
4.86 | — | — | — | |
P/B ratio |
0.68 | — | — | — | |
Price to Tangible BV |
1.74 | — | — | — | |
EV/Sales |
0.25 | — | — | — | |
EV/EBITDA |
4.89 | — | — | — | |
EV/Operating CF |
3.18 | — | — | — | |
EV/FCF |
5.37 | — | — | — | |
Quick Ratio |
0.36 | 0.45 | 0.24 | 0.21 | |
Current Ratio |
0.70 | 0.83 | 0.56 | 0.51 | |
Net Debt/EBITDA |
7.79 | (18.32) | (30.53) | 9.05 | |
Debt/Assets |
22.23% | 24.34% | 25.82% | 27.34% | |
Debt/Equity |
1.49 | 2.11 | 6.12 | 10.58 | |
Asset Turnover |
0.98 | 0.98 | 1.08 | 1.08 | |
Operating CF/Net income |
2.85 | (1.85) | 0.49 | (0.57) | |
Capex/Depreciation |
(0.30) | (0.29) | (0.24) | (0.30) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
19.53% | 18.40% | 20.96% | 20.61% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.06 | 0.05 | |
Share Based Compensation of Revenue |
0.05% | (0.18%) | (0.18%) | (0.03%) | |
Graham Net Nets |
(5.76) | — | — | — | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(71.87%) | — | — | — | |
Free Cash Flow Yield |
45.58% | — | — | — | |
Revenue per Share |
1.71 | 1.93 | 1.69 | 1.65 | |
Operating CF per Share |
0.14 | 0.40 | (0.27) | 0.06 | |
Capex per Share |
(0.03) | (0.03) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.11 | 0.37 | (0.30) | 0.03 | |
Cash per Share |
0.51 | 0.74 | 0.37 | 0.26 | |
Shareholders Equity per Share |
1.01 | 0.78 | 0.26 | 0.16 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.01 | 0.78 | 0.26 | 0.16 | |
Free Cash Flow |
52.58 | 180.68 | (146.60) | 13.61 | |
Working Capital |
(373.26) | (219.22) | (742.51) | (816.34) | |
Capital Expenditures |
(17.04) | (13.73) | (12.91) | (14.59) | |
Net Current Asset Value |
(1,949.28) | (1,870.16) | (2,003.26) | (2,186.60) | |
EV/EBIT |
0.00 | — | — | — | |
Capex to Sales |
0.02 | 0.01 | 0.02 | 0.02 | |
Net Profit Margin |
2.92% | (11.08%) | (32.85%) | (6.01%) | |
Price to Operating Income |
0.00 | — | — | — | |
| Other line items | |||||
Average Receivables |
202.27 | 204.69 | 187.06 | 201.64 | |
Average Payables |
477.67 | 580.26 | 466.38 | 435.70 | |
Average Inventory |
356.17 | 362.48 | 367.58 | 349.93 | |
Average Assets |
3,439.60 | 3,476.52 | 3,187.90 | 3,187.51 | |
Average Common Equity |
611.80 | 462.28 | 301.52 | 266.74 |
Columns are period end dates